Kayleigh is a systematic reviewer for the Cochrane Airways group in the Population Health Research Institute. Her reviews summarise and critically appraise health evidence to inform the care of people with respiratory diseases.
Kayleigh is funded by the NIHR to conduct priority Cochrane reviews in the field of airways disease. Her expertise is in systematic review methodology and meta-analysis. She works as part of the Airways group, one of 53 Cochrane editorial bases. Her current work is a three-year programme grant to analyse and appraise evidence to inform the management, monitoring, and treatment of asthma. Previously, she worked on a suite of reviews to inform the pharmacological management of chronic obstructive pulmonary disease (COPD).
Since she joined the group in 2012, she has published nine systematic reviews, including a network meta-analysis of inhaled therapies for COPD. She is currently working with authors in Australia, Canada, Egypt, India, Sweden and the UK on a total of 13 further reviews to be published by 2017. She also trains GP co-authors based at St George's in review methodology and facilitates training courses run by Cochrane UK. Her reviews are mainly focused on pharmacological treatments for asthma and COPD, but others include cognitive behavioural therapy for asthma, monitoring asthma using fractional exhaled nitric oxide, and tele-healthcare.
Recently, she has collaborated with guideline groups to update national treatment guidance produced by the National Institute for Health and Care Excellence (NICE) and the British Thoracic Society and Scottish Intercollegiate Guidelines Network (BTS/SIGN). Among others, she is a peer reviewer for Cochrane, the NIHR Health Technology Assessment programme, the BMJ and the Journal of Asthma.
Kayleigh has been based within the Cochrane Airways editorial base in the Population Health Research Institute since 2012. Since joining, she has attended conferences in Dublin, Hyderabad, Quebec and Oxford.
She previously worked at the National Collaborating Centre for Mental Health, developing NICE guidance with a team of methodologists and clinicians based at University College London and the Royal College of Psychiatrists.
Before moving into evidence-based medicine, she first worked for two years in the neuropsychology departments of Addenbrooke's and King's College Hospital. She also led a Department of Health project to identify the need for psychological services in stroke rehabilitation.
Kayleigh graduated in 2009 with a degree in Natural Sciences from the University of Cambridge, specialising in Experimental Psychology.
Ahmad S, Kew KM, Normansell R. Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids. Cochrane Database Syst Rev. 2015 Jun 19;6:CD011306. doi: 10.1002/14651858.CD011306.pub2
Kew KM, Evans DJ, Allison DE, Boyter AC. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta(2)-agonists (LABA) for adults with asthma. Cochrane Database Syst Rev. 2015 Jun 2;6:CD011438
Kew KM, Beggs S, Ahmad S. Stopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids. Cochrane Database Syst Rev. 2015 May 21;5:CD011316. doi: 10.1002/14651858.CD011316.pub2
Kew KM, Kirtchuk L, Michell CI. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department. Cochrane Database Syst Rev. 2014 May 28;5:CD010909. doi: 10.1002/14651858.CD010909.pub2
Kew KM, Seniukovich A. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014 Mar 10;3:CD010115. doi: 10.1002/14651858.CD010115.pub2
Kew KM, Dias S, Cates CJ. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta- analysis. Cochrane Database Syst Rev. 2014 Mar 26;3:CD010844. doi: 10.1002/14651858.CD010844.pub2
Christopher Cates, Emma Welsh, Emma Jackson, Elizabeth Stovold, Rebecca Normansell
Dr Chris Cates, Rebecca Normansell, Michael Quinn, Emma Welsh
Janelle Yorke (University of Manchester, UK)
Marina Nashed (Ain Shams University, Egypt)
George Mansour (Creighton University Medical Center, USA)
Debbie Anderson (University of Strathclyde, UK)
Anne Boyter (University of Strathclyde, UK)
David Evans (Lancaster University, UK)
Giovanni Ferrara (Karolinska Institutet, Sweden)
Krishna Undela (JSS University, India)
Helen Petsky (Queensland University of Technology, Australia)
Anne Chang (University of Queensland, Australia)
Benedict Griffiths (Evelina Children's Hospital, UK)
Sean Beggs (University of Tasmania, Australia)
Sofia Dias (University of Bristol, UK)
Alieksei Seniukovich (Grodno Clinic Hospital, Belarus)
May 2014 - May 2017
Evidence to guide care in adults and children with asthma, 13/89/14. National Institute for Healthcare Research (NIHR), UK
November 2012 - April 2014
Reviews of current treatment for COPD and asthma in adults and children. National Institute for Healthcare Research (NIHR), UK